Zhao, D.; Li, H.; Mambetsariev, I.; Chen, C.; Pharaon, R.; Fricke, J.; Baroz, A.R.; Kulkarni, P.; Xing, Y.; Massarelli, E.;
et al. Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors. Cancers 2021, 13, 2653.
https://doi.org/10.3390/cancers13112653
AMA Style
Zhao D, Li H, Mambetsariev I, Chen C, Pharaon R, Fricke J, Baroz AR, Kulkarni P, Xing Y, Massarelli E,
et al. Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors. Cancers. 2021; 13(11):2653.
https://doi.org/10.3390/cancers13112653
Chicago/Turabian Style
Zhao, Dan, Haiqing Li, Isa Mambetsariev, Chen Chen, Rebecca Pharaon, Jeremy Fricke, Angel R. Baroz, Prakash Kulkarni, Yan Xing, Erminia Massarelli,
and et al. 2021. "Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors" Cancers 13, no. 11: 2653.
https://doi.org/10.3390/cancers13112653
APA Style
Zhao, D., Li, H., Mambetsariev, I., Chen, C., Pharaon, R., Fricke, J., Baroz, A. R., Kulkarni, P., Xing, Y., Massarelli, E., Koczywas, M., Reckamp, K. L., Margolin, K., & Salgia, R.
(2021). Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors. Cancers, 13(11), 2653.
https://doi.org/10.3390/cancers13112653
